Acrivon Therapeutics shares owned by Wealthedge Investment Advisors
Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by Wealthedge Investment Advisors
from 13F filings
Historical chart of Wealthedge Investment Advisors investment in Acrivon Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Acrivon Therapeutics held by Wealthedge Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv

Quarterly reported holdings in Acrivon Therapeutics by Wealthedge Investment Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-12-31 | $65k | 11k | 6.02 |
More positions owned by Wealthedge Investment Advisors
View all positions for Wealthedge Investment Advisors